FDA Inspection 973972 — Cambrex Profarmaco Milano Srl

Cambrex Profarmaco Milano Srl — FEI 3003723076

The FDA completed an inspection of Cambrex Profarmaco Milano Srl on November 6, 2015 in Paullo. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 6, 2015
Fiscal Year
2016
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Paullo (Italy)